COPENHAGEN] Novo Nordisk reclaimed its position as Europe’s most valuable public company, overtaking software developer SAP. Read more at The Business Times.

Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization. Novo Nordisk's ADR (NVO) (DK:NOVO.B), at ...

Novo Nordisk jumps 5% as Parvus Asset Management builds a stake to sway CEO succession amid leadership shakeup and pipeline ...

ASX 200 futures are up 24pts (+0.27%) as of 8:30 am AEST. In a nutshell: The S&P 500 and Nasdaq are both within 2.3% of ...

EUROPEAN shares closed little changed on Tuesday in cautious trade as investors awaited the outcome of the second day of ...

The U.S.-listed shares of Danish drugmaker Novo Nordisk rose Tuesday following a report that an activist investor is building ...

Bloomberg says Zuckerberg has prioritized recruiting for the new team, referred internally as a “superintelligence group.” He ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Stock futures posted small gains as talks between the US and China carried into a second day, with investors looking for ...

Novo Nordisk (NYSE:NVO) rose to its highest level in over two months Monday after a media report said hedge fund Parvus Asset ...

Novo Nordisk (NVO) shares hit their highest level in over two months following a Financial Times report that activist hedge ...